GE Healthcare Life Sciences said today that it has entered into a strategic R&D and distribution partnership with Advanced Solutions Life Sciences — with a goal of personalized tissue regeneration.
The partnership with Advanced Solutions Life Sciences is the latest in a string of investments and partnerships that GE Healthcare (NYSE:GE) has been making to further a wide array of medtech innovation — from 3D printing to robot-assisted surgery to artificial intelligence to digital health.
The integration of GE’s IN Cell Analyzer with Advanced Solutions Life Sciences’ BioAssemblyBot systems will involve embedding cellular-level assessments into the 3D-bioprinting workflow used to create human tissue models, according to the companies. The deal is about designing, building and imaging living, vascularized 3D tissues in a single process, according to the companies.
Tell Us What You Think!